Inhibition of angiotensin converting enzyme by phosphonic amides and phosphonic acids.

[1]  W. Greenlee,et al.  Phosphorus-containing inhibitors of angiotensin-converting enzyme. , 1982, Proceedings of the National Academy of Sciences of the United States of America.

[2]  H. Cheung,et al.  Binding of peptide substrates and inhibitors of angiotensin-converting enzyme. Importance of the COOH-terminal dipeptide sequence. , 1980, The Journal of biological chemistry.

[3]  John Leyden. Webb,et al.  Enzyme and metabolic inhibitors , 1963 .

[4]  D W Cushman,et al.  Design of potent competitive inhibitors of angiotensin-converting enzyme. Carboxyalkanoyl and mercaptoalkanoyl amino acids. , 1977, Biochemistry.

[5]  R. Galardy.  Inhibition of angiotensin converting enzyme with Nα-phosphoryl-L-alanyl-L-proline and Nα-phosphoryl-L-valyl-L-tryptophan , 1980 .

[6]  H. Cheung,et al.  Inhibition of homogeneous angiotensin-converting enzyme of rabbit lung by synthetic venom peptides of Bothrops jararaca. , 1973, Biochimica et biophysica acta.

[7]  D W Cushman,et al.  Angiotensin-converting enzyme inhibitors: importance of the amide carbonyl of mercaptoacyl amino acids for hydrogen bonding to the enzyme. , 1982, Journal of medicinal chemistry.

[8]  J. Lowenstein,et al.  Inhibition of adenylosuccinase by adenylophosphonopropionate and related compounds. , 1978, Biochemistry.

[9]  W. L. Jensen,et al.  The Preparation of Phosphonyl Chlorides by the Reaction of Hydrocarbons with Phosphorus Trichloride and Oxygen , 1949 .

[10]  J. Riordan,et al.  Functional residues at the active site of angiotensin converting enzyme. , 1978, Biochemical and biophysical research communications.

[11]  F. R. Atherton,et al.  220. Studies on phosphorylation. Part IV. Further studies on the use of dibenzyl chlorophosphonate and the examination of certain alternative phosphorylation methods , 1948 .

[12]  M. Ondetti,et al.  Angiotensin‐converting enzyme inhibitors: Medicinal chemistry and biological actions , 1982, Medicinal research reviews.

[13]  B. Matthews,et al.  A crystallographic study of the complex of phosphoramidon with thermolysin. A model for the presumed catalytic transition state and for the binding of extended substances. , 1977, Journal of molecular biology.

[14]  R. Soffer,et al.  Pulmonary angiotensin-converting enzyme. Structural and catalytic properties. , 1975, The Journal of biological chemistry.

[15]  R. Galardy,et al.  Inhibition of angiotensin converting enzyme by phosphoramidates and polyphosphates. , 1982, Biochemistry.

[16]  C. A. Stone,et al.  Antihypertensive activity of N-[(S)-1-(ethoxycarbonyl)-3-phenylpropyl]-L-Ala-L-Pro (MK-421), an orally active converting enzyme inhibitor. , 1981, The Journal of pharmacology and experimental therapeutics.

[17]  M. Ondetti,et al.  2 Inhibitiors of Angiotensin-Converting Enzyme , 1980 .